NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University Hospital, Toulouse
Conditions: Alopecia Areata
Countries: France
Alopecia areata (AA) is a complex autoimmune disorder with an estimated lifetime risk of 1.7% where both genetic pre-disposition and environmental factors contribute. It typically presents with sharply demarcated round patches of non-scarring hair loss that may present at any age. Many patients with AA are dissatisfied with current medical treatments and use alternative therapies and cosmetics. This study will generate new data on the current situation of psychosocial and financial burden of AA. It will help to identify unmet needs and to understand the disease issues. It will also be the basis for the planification of future supporting measures.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Adult patients (\> 18 years). * Alopecia Areata whose diagnosis has been confirmed by a dermatologist according to the standardized diagnostic criteria. * \< 2 years duration of current episode of scalp hair loss. * Severity \> S2 (\> 25% hair loss) as assessed by the Alopecia Tool (SALT). Exclusion Criteria: * Patients under juridical protection. * Patients not covered by social security. * Patients unable to understand French
- Toulouse, France